Home › Ovarian Epithelial Carcinoma › Rhode Island
Ovarian Epithelial Carcinoma clinical trials in Rhode Island
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Rhode Island.
Cities in Rhode Island
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Women & Infants Hospital /ID# 274716, Providence
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0191, Providence
RecruitingPhase 1
Ages 18 and older · Women · Updated Apr 7, 2026 · NCT04516447Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Rhode Island Hospital, Providence
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.